An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]
Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]
The advent of PCR methods has enabled the detection and quantification of nucleic acids in small sample sizes. Just recently, […]
A recent study, published in Clinical Chemistry, has presented a rapid nanopore genotyping strategy to enable amplification-free identification and classification […]
Microsatellite instability (MSI) testing of tumour tissue is routinely performed to identify genomic instability (deficiency in one or more DNA […]
Researchers have performed a comprehensive genetic analysis and identified potential drug targets for paediatric germ cell tumours (GCTs). Germ cell […]
As we continue to improve our understanding of cancer biology, one thing remains a game-changer for cancer care: the ability […]
